Latest News of IMAB
AAN 2025: J&J reveals data for nipocalimab, showing long-term disease control in MG
By Yahoo! Finance | 1 week ago
Immunovant's batoclimab shows 'impressive' efficacy in MG, says H.C. Wainwright
By Yahoo! Finance | 3 weeks ago
Johnson & Johnson (NYSE:JNJ) Gains FDA Fast Track For Nipocalimab In Treating Sjogren's Disease
By Yahoo! Finance | 4 weeks ago